OTC
0.76USD
+0.01 (+1.89%)
We have scored 11 news catalysts on Cresco Labs Inc. (CRLBF) over the past 12 months. The biggest single-day move next to one of them came Dec 13, 2025, when CRLBF closed +83.6%: “U.S. Marijuana Stocks Positioned for Growth as Reform Discussions Continue”. Coverage across the window leans positive (average ticker sentiment +0.28). Most of the impact sits in forward growth expectations and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
270.6M
P/E
—
EPS
—
Beta
1.72
52W range
0.588-2.3
Day range
0.72–0.79
Open
0.79
Prev close
0.75
Volume
87.7K
Avg volume
503.7K
Dividend
0.00
IPO
2018-12-03
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Cresco Labs Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of Cresco Labs Inc., taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for CRLBF: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
